Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Biagioni, C, Tirado-Conte, G, Rodés-Cabau, J, Ryan, N, Cerrato, E, Nazif, TM, Eltchaninoff, H, Sondergaard, L, Ribeiro, HB, Barbanti, M, Nietlispach, F, De Jaegere, P, Agostoni, P, Trillo, R, Jiménez-Quevedo, P, D'Ascenzo, F, Wendler, O, Maluenda, G, Chen, M, Tamburino, C, Macaya, C, Leon, MB & Nombela-Franco, L 2018, 'State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries' The Journal of invasive cardiology, vol. 30, no. 8, pp. 301-309.

APA

Biagioni, C., Tirado-Conte, G., Rodés-Cabau, J., Ryan, N., Cerrato, E., Nazif, T. M., ... Nombela-Franco, L. (2018). State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. The Journal of invasive cardiology, 30(8), 301-309.

CBE

Biagioni C, Tirado-Conte G, Rodés-Cabau J, Ryan N, Cerrato E, Nazif TM, Eltchaninoff H, Sondergaard L, Ribeiro HB, Barbanti M, Nietlispach F, De Jaegere P, Agostoni P, Trillo R, Jiménez-Quevedo P, D'Ascenzo F, Wendler O, Maluenda G, Chen M, Tamburino C, Macaya C, Leon MB, Nombela-Franco L. 2018. State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. The Journal of invasive cardiology. 30(8):301-309.

MLA

Vancouver

Biagioni C, Tirado-Conte G, Rodés-Cabau J, Ryan N, Cerrato E, Nazif TM et al. State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. The Journal of invasive cardiology. 2018 Aug;30(8):301-309.

Author

Biagioni, Corina ; Tirado-Conte, Gabriela ; Rodés-Cabau, Josep ; Ryan, Nicola ; Cerrato, Enrico ; Nazif, Tamim M ; Eltchaninoff, Helene ; Sondergaard, Lars ; Ribeiro, Henrique B ; Barbanti, Marco ; Nietlispach, Fabian ; De Jaegere, Peter ; Agostoni, Pierfrancesco ; Trillo, Ramiro ; Jiménez-Quevedo, Pilar ; D'Ascenzo, Fabrizio ; Wendler, Olaf ; Maluenda, Gabriel ; Chen, Mao ; Tamburino, Corrado ; Macaya, Carlos ; Leon, Martin B ; Nombela-Franco, Luis. / State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. In: The Journal of invasive cardiology. 2018 ; Vol. 30, No. 8. pp. 301-309.

Bibtex

@article{52a0f892e305467fb942fbb443e23830,
title = "State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries",
abstract = "BACKGROUND: Transcatheter aortic valve implantation (TAVI) is now the standard treatment for severe aortic stenosis in high-risk symptomatic patients, and its indications are expanding to lower-risk patients.OBJECTIVES: The objective of this study was to analyze the state of TAVI in Spain vs other European and non-European countries.METHODS: Using an online questionnaire, we analyzed the routine practice of 250 TAVI centers worldwide. The questionnaire included 59 questions on patient selection, technical aspects of the procedure, and postprocedural management. The centers were divided into Spain (n = 41), rest of Europe (n = 105), and rest of the world (n = 104).RESULTS: The cumulative number of procedures (74; range, 40-122) and those performed in the last year (16.5; range, 15-29.5) in Spain, were significantly lower than the rest of Europe (P<.01) and the rest of the world (P<.01). The patient risk profile was higher, with an under-use of functional tests compared to the rest of the world. While the use of computed tomography to analyze the aortic annulus was lower in Spain (P<.001), general anesthesia and transesophageal echocardiography were more frequently used in Spain than in the rest of Europe (P<.001 for both). Dual-antiplatelet therapy is the most common post-TAVI antithrombotic therapy in the absence of an indication for anticoagulation, although its duration is longer in Spain (6 months) compared to European centers (3 months).CONCLUSIONS: Routine TAVI practice in Spain differed in some key aspects of preprocedural, intraprocedural, and postprocedural management. Future studies will help to unify strategies and assess their impact on clinical results.",
keywords = "Aged, Aged, 80 and over, Aortic Valve/surgery, Aortic Valve Stenosis/diagnosis, Echocardiography, Transesophageal, Europe, Female, Humans, Male, Patient Selection, Risk Factors, Spain, Transcatheter Aortic Valve Replacement/statistics & numerical data, United States",
author = "Corina Biagioni and Gabriela Tirado-Conte and Josep Rod{\'e}s-Cabau and Nicola Ryan and Enrico Cerrato and Nazif, {Tamim M} and Helene Eltchaninoff and Lars Sondergaard and Ribeiro, {Henrique B} and Marco Barbanti and Fabian Nietlispach and {De Jaegere}, Peter and Pierfrancesco Agostoni and Ramiro Trillo and Pilar Jim{\'e}nez-Quevedo and Fabrizio D'Ascenzo and Olaf Wendler and Gabriel Maluenda and Mao Chen and Corrado Tamburino and Carlos Macaya and Leon, {Martin B} and Luis Nombela-Franco",
year = "2018",
month = "8",
language = "English",
volume = "30",
pages = "301--309",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "H M P Communications, LLC",
number = "8",

}

RIS

TY - JOUR

T1 - State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries

AU - Biagioni, Corina

AU - Tirado-Conte, Gabriela

AU - Rodés-Cabau, Josep

AU - Ryan, Nicola

AU - Cerrato, Enrico

AU - Nazif, Tamim M

AU - Eltchaninoff, Helene

AU - Sondergaard, Lars

AU - Ribeiro, Henrique B

AU - Barbanti, Marco

AU - Nietlispach, Fabian

AU - De Jaegere, Peter

AU - Agostoni, Pierfrancesco

AU - Trillo, Ramiro

AU - Jiménez-Quevedo, Pilar

AU - D'Ascenzo, Fabrizio

AU - Wendler, Olaf

AU - Maluenda, Gabriel

AU - Chen, Mao

AU - Tamburino, Corrado

AU - Macaya, Carlos

AU - Leon, Martin B

AU - Nombela-Franco, Luis

PY - 2018/8

Y1 - 2018/8

N2 - BACKGROUND: Transcatheter aortic valve implantation (TAVI) is now the standard treatment for severe aortic stenosis in high-risk symptomatic patients, and its indications are expanding to lower-risk patients.OBJECTIVES: The objective of this study was to analyze the state of TAVI in Spain vs other European and non-European countries.METHODS: Using an online questionnaire, we analyzed the routine practice of 250 TAVI centers worldwide. The questionnaire included 59 questions on patient selection, technical aspects of the procedure, and postprocedural management. The centers were divided into Spain (n = 41), rest of Europe (n = 105), and rest of the world (n = 104).RESULTS: The cumulative number of procedures (74; range, 40-122) and those performed in the last year (16.5; range, 15-29.5) in Spain, were significantly lower than the rest of Europe (P<.01) and the rest of the world (P<.01). The patient risk profile was higher, with an under-use of functional tests compared to the rest of the world. While the use of computed tomography to analyze the aortic annulus was lower in Spain (P<.001), general anesthesia and transesophageal echocardiography were more frequently used in Spain than in the rest of Europe (P<.001 for both). Dual-antiplatelet therapy is the most common post-TAVI antithrombotic therapy in the absence of an indication for anticoagulation, although its duration is longer in Spain (6 months) compared to European centers (3 months).CONCLUSIONS: Routine TAVI practice in Spain differed in some key aspects of preprocedural, intraprocedural, and postprocedural management. Future studies will help to unify strategies and assess their impact on clinical results.

AB - BACKGROUND: Transcatheter aortic valve implantation (TAVI) is now the standard treatment for severe aortic stenosis in high-risk symptomatic patients, and its indications are expanding to lower-risk patients.OBJECTIVES: The objective of this study was to analyze the state of TAVI in Spain vs other European and non-European countries.METHODS: Using an online questionnaire, we analyzed the routine practice of 250 TAVI centers worldwide. The questionnaire included 59 questions on patient selection, technical aspects of the procedure, and postprocedural management. The centers were divided into Spain (n = 41), rest of Europe (n = 105), and rest of the world (n = 104).RESULTS: The cumulative number of procedures (74; range, 40-122) and those performed in the last year (16.5; range, 15-29.5) in Spain, were significantly lower than the rest of Europe (P<.01) and the rest of the world (P<.01). The patient risk profile was higher, with an under-use of functional tests compared to the rest of the world. While the use of computed tomography to analyze the aortic annulus was lower in Spain (P<.001), general anesthesia and transesophageal echocardiography were more frequently used in Spain than in the rest of Europe (P<.001 for both). Dual-antiplatelet therapy is the most common post-TAVI antithrombotic therapy in the absence of an indication for anticoagulation, although its duration is longer in Spain (6 months) compared to European centers (3 months).CONCLUSIONS: Routine TAVI practice in Spain differed in some key aspects of preprocedural, intraprocedural, and postprocedural management. Future studies will help to unify strategies and assess their impact on clinical results.

KW - Aged

KW - Aged, 80 and over

KW - Aortic Valve/surgery

KW - Aortic Valve Stenosis/diagnosis

KW - Echocardiography, Transesophageal

KW - Europe

KW - Female

KW - Humans

KW - Male

KW - Patient Selection

KW - Risk Factors

KW - Spain

KW - Transcatheter Aortic Valve Replacement/statistics & numerical data

KW - United States

M3 - Journal article

VL - 30

SP - 301

EP - 309

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 8

ER -

ID: 56523812